The CDC reported six new influenza-associated pediatric deaths in Week 6 of 2026, bringing the 2025-2026 U.S. season total to 71. About 90% of deaths with known vaccination status were in children not fully vaccinated.
Moderna announced the FDA will consider approving its mRNA-based flu vaccine for older adults after resolving a dispute over clinical trial design. The vaccine showed 34.5% higher efficacy than standard flu shots in trials.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07314905 |
Adaptive Platform Trial of Treatments for Respiratory Infections in Community Settings (TreatResp) |
RECRUITING | PHASE3 |
| NCT05787444 |
Clinical Validation of the LumiraDx SARS-CoV-2 & Flu A/B Combo Test |
COMPLETED | |
| NCT05728970 |
POC Performance Evaluation of LumiraDx SARS-CoV-2 Ag Ultra and SARS-CoV-2 & Flu A/B Tests. |
COMPLETED |
